Pfizer's Leslie Koby and Dr. Seemal Desai on Advancing Health Equity in Medical Dermatology

The video discusses the significance of HealthEquity in dermatology, highlighting the need for diverse representation in clinical trials and the challenges in diagnosing skin conditions across different skin tones. It emphasizes the importance of education and collaboration between industry and healthcare professionals to improve patient care and access to therapies.

Why is Health Equity particularly important in the field of dermatology?

What are some significant differences in how skin diseases present in different populations?

How does atopic dermatitis disproportionately affect patients of color?

What steps can the industry take to improve diversity in clinical trials?

What role does education play in improving healthcare for diverse patient populations?